Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability.

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Abstract Text:

A Easter,T H Sharp,J-P Valentin,C E Pollard,

INTRODUCTION: Drug-induced seizures are a serious, life-threatening adverse drug reaction (ADR) that can result in the failure of drugs to be licensed for clinical use or withdrawn from the market. Seizure liability of potential drugs is traditionally assessed using animal models run during the later phases of the drug discovery process. Given the low throughput, high animal usage and high compound requirement associated with these assays, it would be advantageous to identify higher throughput, in vitro models that could be used to give an earlier assessment of seizure liability. The hippocampal brain slice is one possibility but conventionally allows recording from only one slice at a time. The aim of this study was to validate a semi-automated system (Slicemaster, Scientifica UK Ltd) which allows concurrent electrophysiological recording from multiple brain slices. METHODS: Conventional electrophysiological recording techniques were used to record electrically evoked synaptic activity from rat hippocampal brain slices. Population spikes (PS) were evoked at 30 s intervals by electrical stimulation of the Schaffer collateral pathway and were recorded using extracellular electrodes positioned in the CA1 cell body layer. Responses were quantified as PS areas (the area above and below the 0 mV line). The effects of eight validation compounds known to cause seizures in vivo and/or in the clinic were assessed. RESULTS: Seven out of eight compounds evoked a concentration-dependent increase in population spike (PS) area that was statistically significant at higher concentrations (P<0.05; ANOVA). At the highest test concentration the percentage effects (mean+/-s.e.m.), relative to vehicle, were: picrotoxin 212.9+/-28.8, pentylenetrazole (PTZ) 181.4+/-24.7, 4-AP 328.9+/-48.6, aminophylline 124.5+/-5.9, chlorpromazine 122.1+/-9.8, SNC-80 132.1+/-12.6 and penicillin 174.7+/-14.1. Physostigmine had no significant effect on PS area although a concentration-dependent change in the morphology of the response was evident. DISCUSSION: All validation compounds evoked a statistically significant effect on synaptic activity in the rat hippocampal slice. Although similar effects have been described previously, this is the first time that the effects of a pharmacologically diverse set of compounds have been assessed using a standardised brain slice assay. Given the low compound usage and relatively high throughput associated with this assay, the hippocampal brain slice assay may facilitate earlier testing of convulsant liability than is currently possible using in vivo models.

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Publishing Authors By Initials

A Easter,TH Sharp,JP Valentin,CE Pollard,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 2007 Sep-Oct

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of pharmacological and toxicological metho

VOLUME: 56

Page Numbers: 223-33

Journal Abbreviation:

ISSN: 1056-8719

DAY: 24

MONTH: 05

YEAR: 2007

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9206091

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability.

AFFILIATION: Safety Assessment UK, AstraZeneca R&D Alderley Park, Macclesfield, SK10 4TG, UK. alison.easter@astrazeneca.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pharmacol Toxicol Methods

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability Related Publications

• A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
• Bayesian analysis of fiber impedance measurements.
• Biased clustered substitutions in the human genome: the footprints of male-driven biased gene conversion.
• Blood transfusion; the indications its technique and dangers.
• Children's participation in vaccine research: parents' views.
• Emerging treatments for viral retinitis.
• Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling.
• INJURIES IN AUSTRALIAN RULES FOOTBALL: A Review of the Literature.
• Incorporation of newly synthesized fatty acids into cytosolic glycerolipids in pea leaves occurs via acyl editing.
• MANAGEMENT OF ACHILLES TENDON DISORDERS: A Case Review.
• Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland.
• Macrophages regulate the angiogenic switch in a mouse model of breast cancer.
• Modern dressings: must do better.
• Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorkstrade mark.
• Peptic ulcer following splanchnicectomy; a report of 13 cases.
• Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability.
• Polymerization kinetics of ADP- and ADP-Pi-actin determined by fluorescence microscopy.
• Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing.
• Promoting healthy survivorship.
• Reconsideration of the use of meningococcal polysaccharide vaccine.
• Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease.
• Regulation of actin filament assembly by Arp2/3 complex and formins.
• SPONDYLOLYSIS IN A PROFESSIONAL FAST BOWLER: A Case Study.
• Single molecule kinetic analysis of actin filament capping. Polyphosphoinositides do not dissociate capping proteins.
• Solastalgia: the distress caused by environmental change.
• Studies of bromine-oxidizable sulfur-containing compounds in mold metabolism.
• The occurrence of gastric neoplasms in youth.
• The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
• Tumor-associated macrophages press the angiogenic switch in breast cancer.
• W135 in Africa: origins, problems and perspectives.